The Dental Roll-Up PlaybookHow PE-backed DSOs build proprietary add-on pipeline.

Defining the mandate

Every dental roll-up stalls for the same reason, and it is rarely the market. It is that the mandate was never written down precisely enough to source against. "Growth-minded GP practices" is a strategy memo, not a sourcing definition — it tells a buy-side team nothing about which of the thousands of independent practices in a region are actually worth a call. The mandate is the first and most underrated document in the entire process, because everything downstream — qualification, approval, cadence — inherits its precision or its vagueness.

A workable mandate answers seven questions in writing before outreach ever begins:

• Sector and specialty mix — general practice, or a specialty lane such as pediatric, orthodontics, oral surgery, periodontics, or endodontics. Most platforms want a defined mix, not "any dentistry."
• Operating structure — a single-location practice ready for its first platform relationship, or a multi-op group of three or more that already behaves like a small DSO.
• Revenue or EBITDA floor — the size below which the deal isn't worth the integration effort, and above which it starts competing with your largest platform additions.
• Associate and hygiene staffing — doctor-to-chair ratios and hygiene program maturity, both strong predictors of how quickly a practice absorbs into a platform's systems.
• Geography — defined at the region or metro level. A mandate written city-by-city sources slower than one written "Sun Belt growth metros" or "multi-region."
• Transition structure appetite — full sale, partial rollover equity, or an earn-out, and whether the seller-dentist is expected to stay clinical, transition out, or split the difference.
• Non-negotiables — the handful of deal-breakers (compliance history, lease term, software stack) that should disqualify a target before a call is ever made, not after diligence has started.

A mandate is not a wish list. It's a sourcing definition — specific enough that a stranger could qualify a target against it without ever speaking to you.

That's the mandate — the sourcing definition everything else in this playbook is built on. The next six sections cover how the market actually gets mapped against it, verified, approved by name, and closed on a fixed cadence. Unlock them below.

Off-market vs. brokered practices

A brokered dental listing is, by design, a competition. The broker's duty runs to the selling dentist, the process is built to maximize the headline multiple, and every credible DSO buyer in the region typically sees the same teaser within weeks. Winning that process means outbidding — which is precisely why platforms that grow primarily through brokered listings tend to pay top-of-range multiples for practices that were never uniquely theirs to begin with.

Off-market changes the starting point of the conversation entirely. A dentist who wasn't actively planning to sell this quarter anchors on fit, culture, and what happens to their patients and staff — not on a broker's opening number. That relationship, built before any transaction is on the table, tends to carry better information into diligence and a smoother post-close transition, because it predates the deal itself.

In dental, the brokered inventory you can see is the inventory every other platform can see too.

This is also where Sentinel's approved track record is worth stating plainly: 95%+ of the practices we bring to partners are unrepresented — genuinely off-market — at the time of first contact. That figure isn't a marketing claim, it's a description of the sourcing method: direct owner outreach at scale, not a subscription to the same inventory everyone else is bidding on.

The honest trade-off

Off-market sourcing takes longer per conversation and requires infrastructure most platforms don't build in-house: full-market data, sustained multilingual outreach, and the discipline to turn hundreds of conversations into a handful of qualified ones. That is exactly why it is usually delegated — the economics of building that machine internally rarely make sense below several acquisitions per year.

Allocation & approval discipline

Discipline is the product, and in a vertical as tight as dental, it's also the most valuable part of the arrangement. Every qualified target is allocated to a single partner at a time — matched on mandate fit, tracked under a defined advancement window. That single sentence is the difference between a proprietary pipeline and a shared one: the same well-run general practice, shopped simultaneously to three DSO platforms, stops being proprietary to any of them the moment a second call is placed.

Approval works the same way. Every target is submitted to the partner in writing before any introduction is made — sector, structure, size, and a summary of the owner conversation. The partner can decline any target, for any reason, with zero pressure to advance. Your name, and your mandate, never travel to an owner-dentist without your sign-off.

Why this matters more in dental than almost anywhere else

Independent dentists talk to each other — at study clubs, continuing-education courses, and through the small professional networks that define most regional markets. A platform whose mandate leaks, or whose target list gets shopped around, doesn't just lose one deal; it can quietly poison an entire region's willingness to take future calls. Confidentiality by policy is not a courtesy in this vertical. It's underwriting for every future conversation in the same region.

Integration-ready criteria

A qualified call and an integration-ready practice are not the same thing, and the gap between them is where most roll-ups lose months in diligence they didn't budget for. Before a target ever reaches a letter of intent, the operating signals below are worth checking — most can be assessed from a management-level conversation, well before a data room opens.

• Practice management software — whether the platform's stack is compatible, and what a migration would actually cost in disruption, not just dollars.
• Associate retention & non-compete terms — clinical continuity after close depends on this more than almost any other single factor.
• Hygiene program maturity — recall compliance and hygiene-to-doctor ratio are strong leading indicators of both revenue quality and how cleanly the practice absorbs a platform's systems.
• Remaining lease term — a short remaining term with no renewal option can quietly cap the practical integration timeline.
• Clinical & chart-audit readiness — a clinician's eye on chart quality and case documentation, applied before diligence, not during it.
• Staffing structure — hygienists and assistants per doctor, and whether current staffing can absorb near-term patient growth without a hiring scramble.

In one engagement, this exact discipline helped a PE-backed DSO platform grow from 25 to 100+ locations. The fund then engaged Sentinel again — this time to launch an entirely new DSO in a new geography from a founding acquisition. Both engagements remain confidential by policy; the pattern is the part worth taking away.

Selected dental closings

That is the full spine of the playbook: a mandate precise enough to source against, a market mapped rather than guessed at, an off-market discipline that keeps targets proprietary, a qualified-call standard held to one definition, allocation and approval that protect your name in a small professional world, a cadence conservative enough to guarantee in writing, and integration criteria checked before diligence rather than during it.